Immunoscoring the lymphocytic infiltration in carcinoid tumours.

Histopathology

Division of Pathology, Department of Diagnostic and Clinical Medicine and of Public Health, University of Modena and Reggio Emilia, Modena, Italy.

Published: June 2017

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13168DOI Listing

Publication Analysis

Top Keywords

immunoscoring lymphocytic
4
lymphocytic infiltration
4
infiltration carcinoid
4
carcinoid tumours
4
immunoscoring
1
infiltration
1
carcinoid
1
tumours
1

Similar Publications

Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment.

Ann Diagn Pathol

December 2024

Department of Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt; Department of Pathology, College of Medicine, Jouf University, 2004 Sakaka 42421, Saudi Arabia.

The immunoscore (ISc) has been extensively investigated as a prognostic indicator for numerous solid tumors. In renal cell carcinoma (RCC), its prognostic significance has been evaluated in a small number of studies. This study was designed to ascertain the prognostic value of ISc based on CD3+ and CD8+ T cells in patients with RCC.

View Article and Find Full Text PDF

A biopsy-based Immunoscore in patients with treatment-naïve resectable gastric cancer.

Ther Adv Med Oncol

October 2024

Department of Pathology, Amsterdam UMC location VUmc, Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Background: The prognostic significance of T-cell densities in gastric cancer (GC) was previously demonstrated in surgical resection specimens. For prognosis or response prediction, it is preferable to identify biomarkers in pre-treatment biopsies; yet, its representativeness of the tumor immune microenvironment is unclear.

Objectives: This study aimed to evaluate the concordance and prognostic value of T-cell densities in paired biopsies and resections.

View Article and Find Full Text PDF

Prognostic and Predictive Value of a Modified Diagnostic Biopsy-Adapted Immunoscore in Patients with Rectal Cancer After Neoadjuvant Treatment: A Translational Study From the STELLAR Trial.

Int J Radiat Oncol Biol Phys

October 2024

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address:

Purpose: The purpose of this study was to assess the prognostic significance of the modified diagnostic biopsy-adapted immunoscore (mIS) in determining the outcomes for patients with locally advanced rectal cancer (LARC) in a neoadjuvant setting.

Methods And Materials: We included 181 patients with LARC from a single subcenter of a prospective study comparing total neoadjuvant therapy (TNT) based on short-course radiation therapy with long-term chemoradiation therapy (CRT). Tumor biopsies at baseline were stained for CD8+ and CD3+ T-cell densities.

View Article and Find Full Text PDF

Tumor-infiltrating lymphocytes (TILs) and immunoscoring based on densities of CD3+ and CD8+ TILs are both favorable prognostic markers in colorectal cancer (CRC). However, determination of the molecular features of TILs, particularly their immunoproteomic signatures would require the development of large scale in situ spatiotemporal technologies. Recently, a multiplex in situ digital spatial proteomic profiling (DSP) tool GeoMx DSP has been applied to identify biomarkers predictive of therapeutic responses and to understand disease mechanisms and progression.

View Article and Find Full Text PDF

Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.

Front Immunol

October 2024

Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.

Article Synopsis
  • Tertiary Lymphoid Structures (TLS) are linked to better cancer patient survival and responses to immunotherapies, but their effectiveness can vary based on size, composition, and maturation.
  • A study on Non-Small Cell Lung Carcinoma (NSCLC) used a multiplex immunofluorescent panel to analyze tumor samples from 406 patients, focusing on specific immune cell types within TLS.
  • The analysis led to a TLS scoring system that identified key features predictive of patient outcomes, showing correlations with other cancer biomarkers but not with PD-L1 status.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!